Evidence map›Paper›PMID 42192900›Full record

ArticleCancers2026

Compartment-Specific CD138 Expression Defines an Aggressive Breast Cancer Phenotype with Distinct Transcriptomic Features.

Kyoko Asai, Takahiro Hasebe, Masahiro Ohara, Masataka Hirasaki, Kazuo Matsuura, Hiroshi Ishiguro, Akihiko Osaki, Toshiaki Saeki

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyoko AsaiDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Takahiro HasebeDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Masahiro OharaDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Masataka HirasakiDepartment of Clinical Cancer Genomics, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.ORCID 0000-0002-9647-2568
Kazuo MatsuuraDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Hiroshi IshiguroDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Akihiko OsakiDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.
Toshiaki SaekiDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City 350-1298, Japan.

Funding

Hidaka Project (2023) 05D107
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerCD138immunohistochemistrymetastasisprognostic biomarkerRNA sequencingsnoRNAsyndecan-1translational reprogrammingtumor microenvironment

Identifiers

PMID42192900
PMCPMC13204842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.